Nuvation Bio Inc.
NUVB
$4.32
-$0.40-8.48%
NYSE
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/13/2026
-
PR Newswire
5/13/2026
-
Insider Monkey
5/12/2026
-
Insider Monkey
5/12/2026
-
TipRanks Financial Blog
5/12/2026
-
Tickeron - Stocks
5/11/2026
-
Simply Wall St
5/10/2026
-
Simply Wall St
5/8/2026
-
Simply Wall St
5/7/2026
-
PR Newswire
5/6/2026
-
Tickeron - Stocks
5/6/2026
-
Tickeron - Stocks
5/6/2026
-
PR Newswire
5/5/2026
-
PR Newswire
5/5/2026
-
MarketBeat
5/5/2026
-
MarketBeat
5/5/2026
-
TipRanks Financial Blog
Nuvation Bio expects gross-to-net to stabilize around 30% as IBTROZI shifts to >50% TKI-naive starts
5/5/2026
-
Seeking Alpha - Healthcare
Nuvation Bio expects gross-to-net to stabilize around 30% as IBTROZI shifts to >50% TKI-naive starts
5/5/2026
-
SeekingAlpha.com: All News
5/5/2026
-
Seeking Alpha: Transcripts
5/5/2026
-
SeekingAlpha
5/5/2026
-
MarketBeat
5/5/2026
-
The Cerbat Gem
5/4/2026
-
Zacks Investment Research
5/4/2026
-
Zacks Investment Research
5/4/2026
-
Fool.com Headlines
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, May 4, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 3 and 7 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
332 208 6102
Address
1500 Broadway
New York, NY 10036
New York, NY 10036
Country
Year Founded
Business Description
Sector
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment. The company’s lead product candidate is IBTROZI (taletrectinib), a...
more